Ahmed Wahid

1.1k total citations
40 papers, 624 citations indexed

About

Ahmed Wahid is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Ahmed Wahid has authored 40 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 14 papers in Hepatology and 10 papers in Molecular Biology. Recurrent topics in Ahmed Wahid's work include Liver Disease Diagnosis and Treatment (10 papers), Drug-Induced Hepatotoxicity and Protection (9 papers) and Hepatitis C virus research (8 papers). Ahmed Wahid is often cited by papers focused on Liver Disease Diagnosis and Treatment (10 papers), Drug-Induced Hepatotoxicity and Protection (9 papers) and Hepatitis C virus research (8 papers). Ahmed Wahid collaborates with scholars based in Egypt, United Kingdom and Saudi Arabia. Ahmed Wahid's co-authors include Jean Dubuisson, Graeme L. Conn, Weam W. Ibrahim, Ahmed S. Kamel, Noha F. Abdelkader, Ashraf Hamed, Mekky M. Abouzied, Heba M. Eltahir, François Helle and Gilles Duverlie and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Molecular Biology.

In The Last Decade

Ahmed Wahid

38 papers receiving 616 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ahmed Wahid Egypt 16 179 165 162 85 60 40 624
Guangyao Zhou China 15 251 1.4× 229 1.4× 137 0.8× 90 1.1× 39 0.7× 38 730
Yawen Zhou China 17 246 1.4× 125 0.8× 42 0.3× 56 0.7× 40 0.7× 38 734
Beatriz San‐Miguel Spain 14 230 1.3× 244 1.5× 102 0.6× 72 0.8× 62 1.0× 20 813
Renate Bang Germany 11 273 1.5× 144 0.9× 133 0.8× 229 2.7× 29 0.5× 11 857
Hyuck Kim South Korea 17 385 2.2× 130 0.8× 55 0.3× 79 0.9× 35 0.6× 55 827
Lingling Han China 20 280 1.6× 403 2.4× 401 2.5× 32 0.4× 41 0.7× 51 1.0k
Yuanling Huang China 13 240 1.3× 203 1.2× 41 0.3× 23 0.3× 76 1.3× 24 643
Afaf A. Ain-Shoka Egypt 13 146 0.8× 90 0.5× 43 0.3× 66 0.8× 66 1.1× 21 555
Bo Jin China 15 255 1.4× 159 1.0× 75 0.5× 48 0.6× 27 0.5× 42 739
Hamid Amouzadeh United States 13 173 1.0× 87 0.5× 193 1.2× 433 5.1× 14 0.2× 31 939

Countries citing papers authored by Ahmed Wahid

Since Specialization
Citations

This map shows the geographic impact of Ahmed Wahid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahmed Wahid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahmed Wahid more than expected).

Fields of papers citing papers by Ahmed Wahid

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ahmed Wahid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahmed Wahid. The network helps show where Ahmed Wahid may publish in the future.

Co-authorship network of co-authors of Ahmed Wahid

This figure shows the co-authorship network connecting the top 25 collaborators of Ahmed Wahid. A scholar is included among the top collaborators of Ahmed Wahid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ahmed Wahid. Ahmed Wahid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Nassra, Rasha A., Ahmed Wahid, Daniel Merk, et al.. (2025). Novel thiazolones for the simultaneous modulation of PPARγ, COX-2 and 15-LOX to address metabolic disease-associated portal inflammation. European Journal of Medicinal Chemistry. 289. 117415–117415. 4 indexed citations
3.
Kamal, Ahmed, et al.. (2024). Relevance of PNPLA3, TM6SF2, HSD17B13, and GCKR Variants to MASLD Severity in an Egyptian Population. Genes. 15(4). 455–455. 4 indexed citations
4.
Wahid, Ahmed, et al.. (2023). Nicorandil reduces morphine withdrawal symptoms, potentiates morphine antinociception, and ameliorates liver fibrosis in rats. Life Sciences. 319. 121522–121522. 13 indexed citations
5.
Wahid, Ahmed, et al.. (2023). Pharmacogenomics in practice: a review and implementation guide. Frontiers in Pharmacology. 14. 1189976–1189976. 49 indexed citations
6.
Ibrahim, Weam W., Ahmed S. Kamel, Ahmed Wahid, & Noha F. Abdelkader. (2022). Dapagliflozin as an autophagic enhancer via LKB1/AMPK/SIRT1 pathway in ovariectomized/d-galactose Alzheimer’s rat model. Inflammopharmacology. 30(6). 2505–2520. 44 indexed citations
9.
Wahid, Ahmed, et al.. (2020). Dietary fiber of psyllium husk (Plantago ovata) as a potential antioxidant and hepatoprotective agent against CCl4-induced hepatic damage in rats. South African Journal of Botany. 130. 208–214. 17 indexed citations
10.
Abouzied, Mekky M., et al.. (2020). A study of the hepatoprotective effect of Plantago psyllium L. seed extract against Carbon tetrachloride induced hepatic injury in rats. Journal of Applied Biomedicine. 18(2-3). 80–86. 4 indexed citations
12.
Wahid, Ahmed, et al.. (2018). Two novel SNPs in the promoter region of PKR gene in hepatitis C patients and their impact on disease outcome and response to treatment. Arab Journal of Gastroenterology. 19(3). 106–115. 1 indexed citations
13.
Wahid, Ahmed, et al.. (2018). RNA protein kinase SNP at −226 C<T is a biomarker for the clearance of HCV among Egyptian patients. Immunological Investigations. 48(3). 211–221. 4 indexed citations
14.
Gad, Gamal F. M., et al.. (2018). Impact of IL-27p28 (rs153109) and TNF-α (rs1800629) Genetic Polymorphisms on the Progression of HCV Infection in Egyptian Patients. Immunological Investigations. 48(3). 255–267. 11 indexed citations
15.
Magrì, Andrea, А. А. Озеров, V. L. Tunitskaya, et al.. (2016). Exploration of acetanilide derivatives of 1-(ω-phenoxyalkyl)uracils as novel inhibitors of Hepatitis C Virus replication. Scientific Reports. 6(1). 29487–29487. 13 indexed citations
16.
Abdel‐Hamid, Nabil Mohie, et al.. (2016). Serum serotonin as unexpected potential marker for staging of experimental hepatocellular carcinoma. Biomedicine & Pharmacotherapy. 83. 407–411. 19 indexed citations
17.
Afzal, Muhammad Sohail, et al.. (2014). HCV Genotype 4; A Brief Review. Journal of Gastroenterology and Hepatology Research. 3(2). 968–976. 2 indexed citations
18.
Anjum, Sadia, Ahmed Wahid, Muhammad Sohail Afzal, et al.. (2013). Additional Glycosylation Within a Specific Hypervariable Region of Subtype 3a of Hepatitis C Virus Protects Against Virus Neutralization. The Journal of Infectious Diseases. 208(11). 1888–1897. 22 indexed citations
19.
Vausselin, Thibaut, Noémie Calland, Sandrine Belouzard, et al.. (2013). The antimalarial ferroquine is an inhibitor of hepatitis C virus. Hepatology. 58(1). 86–97. 37 indexed citations
20.
Wong, Chi‐Wai, et al.. (2010). Magnesium-Dependent Interaction of PKR with Adenovirus VAI. Journal of Molecular Biology. 402(4). 638–644. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026